A citation-based method for searching scientific literature

Subramaniam Mohana Devi, Iyer Mahalaxmi, Nair P Aswathy, Venkatesan Dhivya, Vellingiri Balachandar. Acta Neurol Belg 2020
Times Cited: 14







List of co-cited articles
41 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Unraveling correlative roles of dopamine transporter (DAT) and Parkin in Parkinson's disease (PD) - A road to discovery?
Kaavya Jayaramayya, Mahalaxmi Iyer, Dhivya Venkatesan, Venkatesh Balasubramanian, Arul Narayanasamy, Mohana Devi Subramaniam, Ssang Goo Cho, Balachandar Vellingiri. Brain Res Bull 2020
10
70

Kynurenine pathway in Parkinson's disease-An update.
Dhivya Venkatesan, Mahalaxmi Iyer, Arul Narayanasamy, Kamalakannan Siva, Balachandar Vellingiri. eNeurologicalSci 2020
20
28

Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson's Disease.
Kuo-Hsuan Chang, Mei-Ling Cheng, Hsiang-Yu Tang, Cheng-Yu Huang, Yih-Ru Wu, Chiung-Mei Chen. Mol Neurobiol 2018
55
21

The association between multiple risk factors, clinical correlations and molecular insights in Parkinson's disease patients from Tamil Nadu population, India.
Dhivya Venkatesan, Mahalaxmi Iyer, Robert Wilson S, Lakshmipathy G, Balachandar Vellingiri. Neurosci Lett 2021
5
60

Mitochondrial calcium uniporter as a potential therapeutic strategy for Alzheimer's disease.
Anila Venugopal, Mahalaxmi Iyer, Venkatesh Balasubramanian, Balachandar Vellingiri. Acta Neuropsychiatr 2020
7
28

Retinal vessel diameter obtained by optical coherence tomography is spared in Parkinson's disease.
Duygu Gulmez Sevim, Metin Unlu, Serap Sonmez, Murat Gultekin, Cagatay Karaca, Ayse Ozturk Oner. Int Ophthalmol 2019
6
33

Spectral-Domain OCT Measurements in Alzheimer's Disease: A Systematic Review and Meta-analysis.
Victor T T Chan, Zihan Sun, Shumin Tang, Li Jia Chen, Adrian Wong, Clement C Tham, Tien Y Wong, Christopher Chen, M Kamran Ikram, Heather E Whitson,[...]. Ophthalmology 2019
123
14

Development of a prediction formula of Parkinson disease severity by optical coherence tomography.
Beatriz Jiménez, Francisco J Ascaso, José A Cristóbal, Javier López del Val. Mov Disord 2014
57
14

Retinal nerve fiber layer thickness in Parkinson disease.
Serkan Kirbas, Kemal Turkyilmaz, Ahmet Tufekci, Mustafa Durmus. J Neuroophthalmol 2013
73
14

Distribution of retinal layer atrophy in patients with Parkinson disease and association with disease severity and duration.
Elena Garcia-Martin, Jose M Larrosa, Vicente Polo, Maria Satue, Marcia L Marques, Raquel Alarcia, Maria Seral, Isabel Fuertes, Sofia Otin, Luis E Pablo. Am J Ophthalmol 2014
90
14

Retinal Nerve Fiber Layer Thinning in Alzheimer's Disease: A Case-Control Study in Comparison to Normal Aging, Parkinson's Disease, and Non-Alzheimer's Dementia.
Jagan A Pillai, Robert Bermel, Aaron Bonner-Jackson, Alexander Rae-Grant, Hubert Fernandez, James Bena, Stephen E Jones, Justis P Ehlers, James B Leverenz. Am J Alzheimers Dis Other Demen 2016
62
14

Decreased dopamine in the retinas of patients with Parkinson's disease.
C Harnois, T Di Paolo. Invest Ophthalmol Vis Sci 1990
249
14

Changes in kynurenine pathway metabolism in Parkinson patients with L-DOPA-induced dyskinesia.
Jesper F Havelund, Andreas D Andersen, Michael Binzer, Morten Blaabjerg, Niels H H Heegaard, Egon Stenager, Nils J Faergeman, Jan Bert Gramsbergen. J Neurochem 2017
53
14

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex.
M F Beal, W R Matson, E Storey, P Milbury, E A Ryan, T Ogawa, E D Bird. J Neurol Sci 1992
162
14

Kynurenine metabolism in plasma and in red blood cells in Parkinson's disease.
Zsuzsanna Hartai, Peter Klivenyi, Tamas Janaky, Botond Penke, Laszlo Dux, Laszlo Vecsei. J Neurol Sci 2005
62
14

Age- and disease-specific changes of the kynurenine pathway in Parkinson's and Alzheimer's disease.
Freek J H Sorgdrager, Yannick Vermeiren, Martijn Van Faassen, Claude van der Ley, Ellen A A Nollen, Ido P Kema, Peter P De Deyn. J Neurochem 2019
39
14

Involvement of the kynurenine pathway in the pathogenesis of Parkinson's disease.
Chai K Lim, Francisco J Fernández-Gomez, Nady Braidy, Cristina Estrada, Cristina Costa, Silvia Costa, Alban Bessede, Emiliano Fernandez-Villalba, Anna Zinger, Maria Trinidad Herrero,[...]. Prog Neurobiol 2017
74
14

Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
H-Q Wu, A Rassoulpour, R Schwarcz. J Neural Transm (Vienna) 2007
100
14

Impaired metabolism of kynurenine and its metabolites in CSF of parkinson's disease.
Kazuhiro Iwaoka, Chigumi Otsuka, Tetsuya Maeda, Kanako Yamahara, Kanako Kato, Kenta Takahashi, Kai Takahashi, Yasuo Terayama. Neurosci Lett 2020
17
14

Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Daniela Silva-Adaya, Verónica Pérez-De La Cruz, Juana Villeda-Hernández, Paul Carrillo-Mora, Irma Gabriela González-Herrera, Esperanza García, Laura Colín-Barenque, José Pedraza-Chaverrí, Abel Santamaría. Neurotoxicol Teratol 2011
47
14

Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites.
William R Wikoff, Andrew T Anfora, Jun Liu, Peter G Schultz, Scott A Lesley, Eric C Peters, Gary Siuzdak. Proc Natl Acad Sci U S A 2009
14



Cell replacement therapy is the remedial solution for treating Parkinson's disease.
Venkatesan Dhivya, Vellingiri Balachandar. Stem Cell Investig 2017
8
25

Epidemiology and treatment of Parkinson's disease in India.
Bhim Singhal, Jimmy Lalkaka, Charu Sankhla. Parkinsonism Relat Disord 2003
18
14

The epidemiology of Parkinson's disease: risk factors and prevention.
Alberto Ascherio, Michael A Schwarzschild. Lancet Neurol 2016
696
14


Mitochondrial dysfunction: A hidden trigger of autism?
Vellingiri Balachandar, Kamarajan Rajagopalan, Kaavya Jayaramayya, Madesh Jeevanandam, Mahalaxmi Iyer. Genes Dis 2020
9
22

α-synuclein in the inner retina in parkinson disease.
Ivan Bodis-Wollner, Piotr B Kozlowski, Sofya Glazman, Shahnaz Miri. Ann Neurol 2014
102
14

Assessment of Neurodegeneration by Optical Coherence Tomography and Mini-Mental Test in Parkinson's Disease.
Demet Yıldız, Nilüfer Büyükkoyuncu Pekel, Neslihan Parmak Yener, Meral Seferoğlu, Aygül Günes, Deniz Sığırlı. Ann Indian Acad Neurol 2019
4
50

MDS clinical diagnostic criteria for Parkinson's disease.
Ronald B Postuma, Daniela Berg, Matthew Stern, Werner Poewe, C Warren Olanow, Wolfgang Oertel, José Obeso, Kenneth Marek, Irene Litvan, Anthony E Lang,[...]. Mov Disord 2015
14

Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.
Jonah Doustar, Tania Torbati, Keith L Black, Yosef Koronyo, Maya Koronyo-Hamaoui. Front Neurol 2017
68
14

Phosphorylated α-synuclein in the retina is a biomarker of Parkinson's disease pathology severity.
Isabel Ortuño-Lizarán, Thomas G Beach, Geidy E Serrano, Douglas G Walker, Charles H Adler, Nicolás Cuenca. Mov Disord 2018
70
14

Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer's disease.
Yosef Koronyo, David Biggs, Ernesto Barron, David S Boyer, Joel A Pearlman, William J Au, Shawn J Kile, Austin Blanco, Dieu-Trang Fuchs, Adeel Ashfaq,[...]. JCI Insight 2017
214
14

Outer Retinal Assessment Using Spectral-Domain Optical Coherence Tomography in Patients With Alzheimer's and Parkinson's Disease.
Atsuro Uchida, Jagan A Pillai, Robert Bermel, Aaron Bonner-Jackson, Alexander Rae-Grant, Hubert Fernandez, James Bena, Stephen E Jones, James B Leverenz, Sunil K Srivastava,[...]. Invest Ophthalmol Vis Sci 2018
32
14

Role of RhoA-ROCK signaling in Parkinson's disease.
Mahalaxmi Iyer, Mohana Devi Subramaniam, Dhivya Venkatesan, Ssang-Goo Cho, Matias Ryding, Morten Meyer, Balachandar Vellingiri. Eur J Pharmacol 2021
10
20


Evaluation of the genetic alterations in direct and indirect exposures of hexavalent chromium [Cr(VI)] in leather tanning industry workers North Arcot District, South India.
Vellingiri Balachandar, Meyyazhagan Arun, Subramaniam Mohana Devi, Palanivel Velmurugan, Pappusamy Manikantan, Alagamuthu Karthick Kumar, Keshavarao Sasikala, Chinnakulandai Venkatesan. Int Arch Occup Environ Health 2010
23
14


The role of oxidative stress in Parkinson's disease.
Vera Dias, Eunsung Junn, M Maral Mouradian. J Parkinsons Dis 2013
830
14

Metals and Parkinson's Disease: Mechanisms and Biochemical Processes.
Geir Bjorklund, Vera Stejskal, Mauricio A Urbina, Maryam Dadar, Salvatore Chirumbolo, Joachim Mutter. Curr Med Chem 2018
62
14

Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors.
D S Hui, G M Joynt, K T Wong, C D Gomersall, T S Li, G Antonio, F W Ko, M C Chan, D P Chan, M W Tong,[...]. Thorax 2005
244
7

[Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia].
M Liu, P He, H G Liu, X J Wang, F J Li, S Chen, J Lin, P Chen, J H Liu, C H Li. Zhonghua Jie He He Hu Xi Za Zhi 2020
63
7

Neurological Complications of Coronavirus Disease (COVID-19): Encephalopathy.
Asia Filatov, Pamraj Sharma, Fawzi Hindi, Patricio S Espinosa. Cureus 2020
334
7

COVID-19: emerging protective measures.
V Balachandar, I Mahalaxmi, J Kaavya, G Vivekanandhan, S Ajithkumar, N Arul, G Singaravelu, N Senthil Kumar, S Mohana Dev. Eur Rev Med Pharmacol Sci 2020
35
7

SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases.
Tai-Nin Chau, Kam-Cheong Lee, Hung Yao, Tak-Yin Tsang, Tat-Chong Chow, Yiu-Cheong Yeung, Kin-Wing Choi, Yuk-Keung Tso, Terence Lau, Sik-To Lai,[...]. Hepatology 2004
230
7

COVID-19: an update on diagnostic and therapeutic approaches.
Mahalaxmi Iyer, Kaavya Jayaramayya, Mohana Devi Subramaniam, Soo Bin Lee, Ahmed Abdal Dayem, Ssang-Goo Cho, Balachandar Vellingiri. BMB Rep 2020
32
7

COVID-19: consider cytokine storm syndromes and immunosuppression.
Puja Mehta, Daniel F McAuley, Michael Brown, Emilie Sanchez, Rachel S Tattersall, Jessica J Manson. Lancet 2020
7

Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study.
Fang Tang, Yan Quan, Zhong-Tao Xin, Jens Wrammert, Mai-Juan Ma, Hui Lv, Tian-Bao Wang, Hong Yang, Jan H Richardus, Wei Liu,[...]. J Immunol 2011
314
7

TMPRSS2: A potential target for treatment of influenza virus and coronavirus infections.
Li Wen Shen, Hui Juan Mao, Yan Ling Wu, Yoshimasa Tanaka, Wen Zhang. Biochimie 2017
160
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.